BAXTER INTERNATIONAL INC (BAX)
BAXTER INTERNATIONAL INC (BAX) from its SEC filings: 2025 revenue $11.2 billion (+6% vs the year before), net margin -8%, free cash flow $845.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $11.2 billion |
| Revenue growth | +6% |
| Net income | -$957.0 million |
| Net margin | -8.5% |
| Free cash flow | $845.0 million |
| Diluted EPS | $-1.87 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +5% |
| Cash | $2.1 billion |
| Long-term debt | $9.4 billion |
| Share count, 1 year | +1% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.